UCB, INC.

Lobbying for UCB, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $710,000.00 expenses · posted Jul 17, 2026

Bills named in this filing 6

Lobbying activity 2

Pharmacy

H.R. 5509/S. 2903 - Safe Step Act H.R. 6423/S. 864 - HELP Copays Act H.R. 1189/S. 494 - National Plan for Epilepsy Act Drug Pricing

Trade (domestic/foreign)

Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.